These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
209 related articles for article (PubMed ID: 9097368)
1. New antiepileptic drugs: case studies. Bannister SM; Morton LD; Pellock JM Semin Pediatr Neurol; 1997 Mar; 4(1):64-7. PubMed ID: 9097368 [No Abstract] [Full Text] [Related]
2. Efficacy and tolerability of the new antiepileptic drugs II: treatment of refractory epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society. French JA; Kanner AM; Bautista J; Abou-Khalil B; Browne T; Harden CL; Theodore WH; Bazil C; Stern J; Schachter SC; Bergen D; Hirtz D; Montouris GD; Nespeca M; Gidal B; Marks WJ; Turk WR; Fischer JH; Bourgeois B; Wilner A; Faught RE; Sachdeo RC; Beydoun A; Glauser TA; ; ; Neurology; 2004 Apr; 62(8):1261-73. PubMed ID: 15111660 [TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics and interaction profile of topiramate: review and comparison with other newer antiepileptic drugs. Johannessen SI Epilepsia; 1997; 38 Suppl 1():S18-23. PubMed ID: 9092953 [TBL] [Abstract][Full Text] [Related]
9. Efficacy and tolerability of the new antiepileptic drugs I: treatment of new onset epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society. French JA; Kanner AM; Bautista J; Abou-Khalil B; Browne T; Harden CL; Theodore WH; Bazil C; Stern J; Schachter SC; Bergen D; Hirtz D; Montouris GD; Nespeca M; Gidal B; Marks WJ; Turk WR; Fischer JH; Bourgeois B; Wilner A; Faught RE; Sachdeo RC; Beydoun A; Glauser TA; ; ; Neurology; 2004 Apr; 62(8):1252-60. PubMed ID: 15111659 [TBL] [Abstract][Full Text] [Related]
11. Antiepileptic drug review: part 2. Winkler SR; Luer MS Surg Neurol; 1998 May; 49(5):566-8. PubMed ID: 9586938 [No Abstract] [Full Text] [Related]
12. Prognostic factors for time to treatment failure and time to 12 months of remission for patients with focal epilepsy: post-hoc, subgroup analyses of data from the SANAD trial. Bonnett L; Smith CT; Smith D; Williamson P; Chadwick D; Marson AG Lancet Neurol; 2012 Apr; 11(4):331-40. PubMed ID: 22377180 [TBL] [Abstract][Full Text] [Related]
13. New antiepileptic drugs: a systematic review of their efficacy and tolerability. Marson AG; Kadir ZA; Chadwick DW BMJ; 1996 Nov; 313(7066):1169-74. PubMed ID: 8916746 [TBL] [Abstract][Full Text] [Related]
15. Use of new antiepileptic drugs in the treatment of childhood epilepsy. Pellock JM; Appleton R Epilepsia; 1999; 40 Suppl 6():S29-38; discussion S73-4. PubMed ID: 10530681 [TBL] [Abstract][Full Text] [Related]
17. Managing pediatric epilepsy syndromes with new antiepileptic drugs. Pellock JM Pediatrics; 1999 Nov; 104(5 Pt 1):1106-16. PubMed ID: 10545555 [TBL] [Abstract][Full Text] [Related]
18. The use of new antiepileptic medications in pediatric patients with epilepsy. Carter JR J Pediatr Health Care; 1994; 8(6):277-82. PubMed ID: 7799203 [No Abstract] [Full Text] [Related]
19. Pharmacokinetics of new antiepileptic drugs. Gram L Epilepsia; 1996; 37 Suppl 6():S12-6. PubMed ID: 8941037 [TBL] [Abstract][Full Text] [Related]